Chocolate n = 48 | Conventional n = 63 | P | |
---|---|---|---|
Patient characteristics | |||
Age, years | 74 ± 8 | 74 ± 9 | 0.900 |
Male, n (%) | 36 (75) | 46 (73) | 0.814 |
Body mass index, kg/m2 | 23.4 ± 4.2 | 23.2 ± 4.0 | 0.682 |
Hypertension, n (%) | 43 (90) | 55 (87) | 0.711 |
Dyslipidemia, n (%) | 28 (58) | 32 (51) | 0.430 |
Diabetes mellitus, n (%) | 31 (65) | 41 (65) | 0.957 |
Chronic kidney disease, n (%) | 31(65) | 46(73) | 0.340 |
Hemodialysis, n (%) | 16 (33) | 27 (43) | 0.308 |
Smoker, n (%) | 10 (21) | 12 (19) | 0.815 |
Aspirin, n (%) | 34 (71) | 48 (76) | 0.525 |
Thienopyridine, n (%) | 41 (85) | 54 (86) | 0.965 |
Cilostazol, n (%) | 12 (25) | 10 (16) | 0.232 |
Prior Coronary artery disease, n (%) | 16 (33) | 28 (44) | 0.236 |
Prior peripheral artery disease, n (%) | 22 (46) | 31 (49) | 0.725 |
Prior cerebrovascular disease, n (%) | 9 (19) | 8 (13) | 0.380 |
Chronic limb-threatening ischemia, n (%) | 10 (21) | 19 (30) | 0.268 |
Lesion characteristics | |||
Pre-ankle brachial index | 0.70 ± 0.16 | 0.65 ± 0.17 | 0.094 |
Post-ankle brachial index | 0.93 ± 0.15 | 0.90 ± 0.19 | 0.744 |
TASCII C/D, n (%) | 20 (42) | 33 (52) | 0.263 |
PACSS 3/4, n (%) | 24 (50) | 33 (52) | 0.804 |
include P2/3 lesion, n (%) | 14 (29) | 24 (38) | 0.326 |
CTO lesion, n (%) | 11 (23) | 22 (35) | 0.170 |
Lesion length, mm | 134 ± 98 | 156 ± 96 | 0.116 |
Vessel diameter, mm | 4.7 ± 0.7 | 4.7 ± 0.9 | 0.468 |
poor run off vessel, n (%) | 14 (29) | 24 (38) | 0.326 |